RAFAEL HOLDINGS, INC. Investment Owned, Percent of Net Assets
RAFAEL HOLDINGS, INC. (RFL) had Investment Owned, Percent of Net Assets of 84.00% as of 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Notes
us-gaap:InvestmentOwnedPercentOfNetAssets · last filed 2024-12-20
- 2024-07-31: Investment Owned, Percent of Net Assets 84.00%.
- 2024-04-30: Investment Owned, Percent of Net Assets 84.00%.
- 2024-01-31: Investment Owned, Percent of Net Assets 84.00%.
- 2023-02-09: Investment Owned, Percent of Net Assets 95.00%.
| Period end | Investment Owned, Percent of Net Assets |
|---|---|
| 2024-07-31 | 84.00% 10-K/A · filed 2024-12-20 |
| 2024-04-30 | 84.00% 10-Q · filed 2024-06-14 |
| 2024-01-31 | 84.00% 10-Q · filed 2024-03-14 |
| 2023-02-09 | 95.00% 10-K/A · filed 2024-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |